Prestige Consumer Healthcare Inc. (PBH): who owns it and who trades it
As of Nov 16, 2026, PBH insiders reported 8 open-market sales worth $424K and no purchases in the last 12 months, with 27% of the sale value made under pre-set 10b5-1 plans. The largest seller was Jeffrey Zerillo (Vice president), with $246K. 5 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Prestige Consumer Healthcare
From the latest filingsOverall: more selling than buying. Insiders mostly sold. Famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Insider trades
In the last 12 months, PBH insiders reported $0 of open-market purchases and $424K of sales. 27% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | Jeffrey Zerillo | Vice president | Sale plan | 351 | $52.28 | $18.4K | Form 4 |
| May 7, 2026 | Jeffrey Zerillo | Vice president | Sale plan | 305 | $54.36 | $16.6K | Form 4 |
| May 5, 2026 | Jeffrey Zerillo | Vice president | Sale | 1,207 | $54.99 | $66.4K | Form 4 |
| May 5, 2026 | Jeffrey Zerillo | Vice president | Sale plan | 346 | $55.32 | $19.1K | Form 4 |
| Feb 11, 2026 | Jeffrey Zerillo | Vice president | Sale | 1,000 | $65.93 | $65.9K | Form 4 |
| Dec 1, 2025 | Jeffrey Zerillo | Vice president | Sale plan | 281 | $60.00 | $16.9K | Form 4 |
| Nov 28, 2025 | Jeffrey Zerillo | Vice president | Sale plan | 719 | $60.00 | $43.1K | Form 4 |
| Nov 25, 2025 | John E Byom | Director | Sale | 3,000 | $59.35 | $178K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Jeffrey Zerillo | Senior VP Operations | – | $246K | May 11, 2026 |
| John E Byom | Director | – | $178K | Nov 25, 2025 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
PBH short interest
Moderate short interest. 9.0% of PBH shares are sold short: about 1 share in 11. Over the last 12 reports the number of shares short went up 58%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 4.24M PBH shares were sold short, 9.0% of the shares outstanding, up 7.1% from the report before. At the average daily volume of 527,165 shares, buying them all back would take about 8.1 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 4.24M | 8.95% | +7% | 527,165 | 8.1 |
| Oct 15, 2026 | 3.96M | 8.36% | -15% | 546,549 | 7.2 |
| Sep 30, 2026 | 4.64M | 9.80% | -3% | 703,849 | 6.6 |
| Sep 15, 2026 | 4.79M | 10.12% | +5% | 507,494 | 9.4 |
| Aug 31, 2026 | 4.58M | 9.68% | +7% | 414,789 | 11.1 |
| Aug 14, 2026 | 4.27M | 9.01% | +12% | 686,887 | 6.2 |
| Jul 31, 2026 | 3.82M | 8.06% | +24% | 471,737 | 8.1 |
| Jul 15, 2026 | 3.09M | 6.52% | -4% | 464,289 | 6.7 |
| Jun 30, 2026 | 3.21M | 6.78% | +10% | 913,240 | 3.5 |
| Jun 15, 2026 | 2.93M | 6.19% | +18% | 638,880 | 4.6 |
| May 29, 2026 | 2.48M | 5.23% | -8% | 732,828 | 3.4 |
| May 15, 2026 | 2.68M | 5.67% | -8% | 965,594 | 2.8 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Prestige Consumer Healthcare company events
Prestige Consumer Healthcare filed 9 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 5, 2026.
- Nov 5, 2026ResultsReleased financial results. Filing
- Aug 14, 2026LeadershipJeffrey Zerillo notified Prestige Consumer Healthcare Inc. of his decision to retire from his position as Senior Vice President, Operations and from all other positions he holds with the Company, effective August 14, 2026. Filing
- Aug 6, 2026ResultsReleased financial results. Filing
- Jul 15, 2026AgreementPrestige Brands, Inc., a wholly owned subsidiary of Prestige Consumer Healthcare Inc., issued $400.0 million of 6.250% senior notes due 2034 pursuant to an Indenture, dated July 15, 2026, among Prestige Brands, the guarantors party thereto (including the Company) and U.S. Bank Trust Company… Filing
- Jul 6, 2026AgreementPrestige Consumer Healthcare Inc. and its wholly-owned subsidiary, Prestige Brands, Inc., entered into an amendment to that certain Term Loan Credit Agreement by and among the Company, the Borrower, certain other subsidiaries of the Company as guarantors, Citibank, N.A. as administrative agent, the… Filing
- Jun 16, 2026DealThe Borrower and Medtech Products Inc., a wholly-owned subsidiary of the Company, completed the previously announced acquisition of Breathe Right® and certain other brands from Foundation Consumer Brands, LLC and certain of its affiliates, pursuant to an Asset Purchase Agreement, dated as of March… Filing
- May 13, 2026AgreementPBH Australia Holding Company Pty Limited, an Australian company and a wholly owned indirect subsidiary of Prestige Consumer Healthcare Inc., and Care Pharmaceuticals Pty Limited, an Australian company and a wholly owned indirect subsidiary of the Company, entered into a definitive agreement with… Filing
- Mar 20, 2026AgreementPrestige Brands, Inc., a Delaware corporation and a wholly-owned subsidiary of Prestige Consumer Healthcare Inc., entered into a definitive agreement with Foundation Consumer Brands, LLC, a Delaware limited liability company. Filing
- Feb 5, 2026ResultsReleased financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Prestige Consumer Healthcare financials
Famous investors that hold PBH
5 of the 50 well-known investors we track reported holding PBH in their latest 13F filing. The largest position is Ken Griffin's, worth $38M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 828,182 | $38M | 0.0% | +47% |
| Israel Englander · Millennium Management | Q3 2026 | 199,397 | $9.1M | 0.0% | +330% |
| Ken Fisher · Fisher Asset Management | Q3 2026 | 158,339 | $7.3M | 0.0% | -36% |
| Lee Ainslie · Maverick Capital | Q3 2026 | 49,831 | $2.3M | 0.0% | -2% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 38,400 | $1.8M | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named PBH in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | FULLER & THALER ASSET MANAGEMENT, INC. | 13G | 5.3% |
| Nov 16, 2026 | FULLER & THALER ASSET MANAGEMENT, INC. | 13G | 5.3% |
Questions about Prestige Consumer Healthcare Inc. (PBH) stock
Are PBH insiders buying or selling?
In the last 12 months, PBH insiders reported no open-market purchases and 8 sales worth $424K. The latest trade was on May 11, 2026. See every trade.
What is the short interest in PBH?
As of Oct 30, 2026, 4.24M PBH shares were sold short, 9.0% of the shares outstanding, up 7.1% from the report before. At the average daily volume of 527,165 shares, buying them all back would take about 8.1 trading days (days to cover). See the history.
Which famous investors hold PBH?
5 of the 50 well-known investors we track reported PBH in their latest 13F filing, including Ken Griffin, Israel Englander, Ken Fisher. The largest position is worth $38M. See all holders.
Executive pay
Prestige Consumer Healthcare's chief executive was paid a total of $6M for the year ended Mar 31, 2026, down 3% from $6.2M the year before. In the last 12 months, Prestige Consumer Healthcare's executives and directors bought no stock on the open market and sold $424K.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.